Kewalramani Reshma's Form 4 filing
Vertex Pharmaceuticals IncVRTX · filed Mar 3, 2026
- Accession no.
- 0000875320-26-000129
- Filed
- Mar 3, 2026
- Trade date
- Feb 27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions. Open-market sales total $19.7M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kewalramani ReshmaCIK 0001735944 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | SSaleDisposed | −400 | $479.75F2,F3 | −$191,900 | 137,878 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −120 | $481.50F2,F4 | −$57,780 | 137,758 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −240 | $482.84F2,F5 | −$115,881.6 | 137,518 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −2,510 | $487.13F2,F6 | −$1,222,696.3 | 135,008 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −3,278 | $488.27F2,F7 | −$1,600,549.06 | 131,730 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −460 | $489.32F2,F8 | −$225,087.2 | 131,270 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −2,725 | $490.54F2,F9 | −$1,336,721.5 | 128,545 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −949 | $491.30F2,F10 | −$466,243.7 | 127,596 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −2,520 | $493.29F2,F11 | −$1,243,090.8 | 125,076 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −3,498 | $494.33F2,F12 | −$1,729,166.34 | 121,578 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −15,580 | $495.38F2,F13 | −$7,718,020.4 | 105,998 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −5,995 | $496.16F2,F14 | −$2,974,479.2 | 100,003 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −1,725 | $496.95F2,F15 | −$857,238.75 | 98,278 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 13 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $479.75 (range $479.75 to $479.76).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $481.50 (range $481.50 to $481.51).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $482.84 (range $482.84 to $482.85).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $487.13 (range $486.64 to $487.55).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $488.27 (range $487.82 to $488.56).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $489.32 (range $489.01 to $489.79).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $490.54 (range $490.10 to $491.01).
Referenced by the price of 1 transaction in Table I.
- F10
Open market sales reported on this line occurred at a weighted average price of $491.30 (range $491.13 to $491.85).
Referenced by the price of 1 transaction in Table I.
- F11
Open market sales reported on this line occurred at a weighted average price of $493.29 (range $492.78 to $493.77).
Referenced by the price of 1 transaction in Table I.
- F12
Open market sales reported on this line occurred at a weighted average price of $494.33 (range $493.78 to $494.75).
Referenced by the price of 1 transaction in Table I.
- F13
Open market sales reported on this line occurred at a weighted average price of $495.38 (range $494.79 to $495.78).
Referenced by the price of 1 transaction in Table I.
- F14
Open market sales reported on this line occurred at a weighted average price of $496.16 (range $495.79 to $496.74).
Referenced by the price of 1 transaction in Table I.
- F15
Open market sales reported on this line occurred at a weighted average price of $496.95 (range $496.79 to $497.17).
Referenced by the price of 1 transaction in Table I.